Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 36%
Hold 21%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated a strong commitment to increasing its advertising expenditures, rising from 11.6% of sales in 2021 to 13.5% in 2024, indicating a strategic focus on enhancing brand visibility and market penetration. The company has successfully grown both price and volume from the second quarter of 2023 through the third quarter of 2024, reflecting a robust demand for its products amidst competitive market conditions. With approximately 70% of its sales derived from international markets, including 45% from emerging regions, Colgate-Palmolive is well-positioned for continued global expansion and revenue growth.

Bears say

Colgate-Palmolive's gross margin experienced a decline of 75 basis points year-over-year in the second quarter of 2025, primarily attributed to rising raw material costs and tariffs. Additionally, the company's volume sales reported declines of 0.3% and 0.9% in the first and second quarters of 2025, respectively, indicating weakening demand despite price growth of 3.2% and 2.9% during the same periods. The dog food category, which is a significant portion of Colgate's business through its Hill's brand, is also facing challenges, with a 2.8% decline in U.S. retail channels for the third quarter of 2025, suggesting broader issues within its product lines.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 36% recommend Buy, 21% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Dec 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.